LFMD Q3 2023 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q3 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$39M+22.9% YoY

Gross Profit

$34M87.6% margin

Operating Income

-$5M-11.8% margin

Net Income

-$6M-15.9% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

+7.4%

Cash Flow

Operating Cash Flow

$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$41M

Total Liabilities

$52M

Stockholders' Equity

-$13M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$31M	+22.9%
Gross Profit	$34M	$27M	+26.7%
Operating Income	-$5M	-$7M	+35.3%
Net Income	-$6M	-$7M	+15.9%